COMMUNIQUÉS West-GlobeNewswire

Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Naturals

26/11/2018 - 22:29

VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, [...]

Amarin Announces Proposed Public Offering of American Depositary Shares

26/11/2018 - 22:23

BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of [...]

Transparency notification

26/11/2018 - 22:02

Mechelen, Belgium; 26 November 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]

G1 Therapeutics Announces Positive Myelopreservation Data from Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Trilaciclib in Combination with Chemotherapy/Tecentriq® in First-Line Small Cell Lung Cancer

26/11/2018 - 22:01

Second randomized, double-blind, placebo-controlled Phase 2 trial confirms multi-lineage myelopreservation benefits of trilaciclib in first-line small cell lung cancer (1L SCLC) Statistically significant improvements in [...]

CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer

26/11/2018 - 22:01

BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]

Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th

26/11/2018 - 22:01

NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will be [...]

Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND

26/11/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced five poster presentations at the 29 th International Symposium on ALS/MND in Glasgow, Scotland, UK. The [...]

VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues

26/11/2018 - 21:16

TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]

Xbrane Biopharma presents nomination committee

26/11/2018 - 20:01

Press release 2018-11-26 In accordance with the principles of the nomination committee of Xbrane Biopharma AB (" Company " or " Xbrane "), adopted at the Annual General Meeting on 24 May 2018, the Nomination Committee [...]

Hair Today, Gone Tomorrow: Dermatologists Debunk Common Misconceptions About Laser Hair Removal; American Academy of Dermatology

26/11/2018 - 20:00

AAD warns consumers that laser hair removal can be dangerous in inexperienced hands ROSEMONT, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- When performed by a doctor, laser hair removal is a safe, effective and permanent [...]

iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018

26/11/2018 - 18:21

Clinical results presented demonstrate outstanding outcomes with world-class artificial intelligence NASHUA, N.H. and CHICAGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- (Booth #3911 and #8161) – iCAD, Inc. (NASDAQ: ICAD), a [...]

Sanofi: Disclosure of trading in own shares

26/11/2018 - 18:01

Attachment Reporting EN.pdf

Sanofi : Déclaration des transactions sur actions propres

26/11/2018 - 18:01

Pièce jointe Reporting FR.pdf

OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127

26/11/2018 - 18:00

NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announced authorization by Federal Agency for Medicines and Health Products (FAMH) and Belgian Ethics [...]

Opthea Confirms Final Patient Enrolment in Phase 2b Wet AMD Clinical Trial

26/11/2018 - 17:32

MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, is pleased to report that the last [...]

Vital® Celebrates 30 Years of Leadership at RSNA 2018

26/11/2018 - 17:26

A global leader in healthcare imaging, Vital is excited to share its latest innovations in enterprise imaging MINNETONKA, Minn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Built on 30 years of innovation and leadership in [...]

Ossur Hf : Transactions in relation to share buyback program

26/11/2018 - 17:01

Announcement no. 68/2018 26 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Zealand Pharma announces change in Executive Management

26/11/2018 - 16:00

Company announcement – No. 29/2018 Zealand Pharma announces change in Executive Management Copenhagen, Denmark, November 26, 2018 – Zealand Pharma A/S announces that Britt Meelby Jensen has today delivered her notice to [...]

Emisphere Development Update

26/11/2018 - 15:36

ROSELAND, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced the completion and results on Thursday, November 22 and Friday, November 23 regarding their Pioneer 9 and Pioneer 6 phase 3a trials, both [...]